The Drugs for Neglected Diseases Initiative (DNDi) is a collaborative, patient needs–driven, nonprofit drug research and development (R&D) organization that is developing new treatments for neglected diseases. DNDi is working on the following diseases: leishmaniasis, sleeping sickness (human African trypanosomiasis, HAT), Chagas disease, and malaria. In 2011, DNDi started to take on specific projects for two new disease areas: pediatric HIV and filarial diseases.
No takes yet. Share an insight, caveat, or question.
Kevin M Wasunna (2005) studied this question.